Abstract:High biocompatibility cell membrane of over‐expression transferrin camouflaged polymer nanoparticles (SPN‐TF) exhibit strong light absorption and excellent photothermal conversion in NIR‐II optical window with superior photostability. Furthermore, SPN‐TF nanoparticles can efficiently be taken up by cancer cells and possess outstanding anticancer ability in vitro and in vivo under 1064 nm laser irradiation. The SPN‐TF nanoparticles exhibit an excellent photothermal conversion ability, predominant targeting efficiency, and superb PTT for anti‐cancer both in vitro and in vivo. Tumor‐selective near infrared‐induced photothermal therapy is a successful approach for ablation of malignant and cancerous cells. In the NIR region, tissue penetration depth in the near‐infrared second region (NIR‐II, 1000–1700 nm) is deeper than that of the traditional near‐infrared first region (NIR‐I, 700–900 nm) for the lower scattering and absorption. However, there are few photothermal conversion agents (PCAs) in the NIR‐II. And these PCAs are quickly identified by the immune system and rapidly cleared by the reticuloendothelial system (RES), leading to low accumulation in tumor, which prevents further advanced clinical practice. In this work, the conjugated polymer, PBTPBFTDPP, is prepared and assembled into nanoparticles (SPN). Then, the genetically engineered cell membranes are coated on the surface of SPN to obtain the positive targeting ability (SPN‐TF). The obtained SPN‐TF nanoparticles exhibit an excellent photothermal conversion ability, predominant targeting efficiency, and superb photothermal therapy for anticancer both in vitro and in vivo. These works will inspire more translational work on SPN for future clinical applications.

Functionalized Magnetic Nanoparticles for NIR-Induced Photothermal Therapy of Potential Application in Cervical Cancer

Magnetic Nanoparticle Clusters for Photothermal Therapy with Near-Infrared Irradiation.

Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy.

Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy

880 nm NIR-Triggered Organic Small Molecular-Based Nanoparticles for Photothermal Therapy of Tumor

Nuclear‐Targeted Multifunctional Magnetic Nanoparticles for Photothermal Therapy

Photothermal therapy of xenografted tumor by carbon nanoparticles-Fe(II) complex

NIR Photothermal Therapy Using Polyaniline Nanoparticles

Synthesis of an efficient paramagnetic ZnFe2O4 agent for NIR-I/II responsive photothermal performance

Biocompatible Calcium Ion-Doped Magnesium Ferrite Nanoparticles as a New Family of Photothermal Therapeutic Materials for Cancer Treatment

Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy

Fe-doped Copper Sulfide Nanoparticles for in Vivo Magnetic Resonance Imaging and Simultaneous Photothermal Therapy.

Genetically Engineered Cell Membrane Modified Conjugated Polymer Nanoparticles for NIR‐II Photothermal Therapy

Multifunctional Fe5C2 Nanoparticles: A Targeted Theranostic Platform for Magnetic Resonance Imaging and Photoacoustic Tomography‐Guided Photothermal Therapy

Inorganic Nanoparticles for Photothermal Treatments of Cancer

J-aggregates of multi-groups cyanine dye for NIR-IIa fluorescence-guided mild photothermal therapy under 1064 nm irradiation

Novel small molecule-based organic nanoparticles for second near-infrared photothermal tumor ablation

Engineering nanofusiform Iron-doped polydiaminopyridine boost intratumoral penetration for immunogenic cell Death-mediated synergistic Photothermal/Chemo therapy

Highly Efficient 2D NIR‐II Photothermal Agent with Fenton Catalytic Activity for Cancer Synergistic Photothermal–Chemodynamic Therapy

Biodegradable π-Conjugated Oligomer Nanoparticles with High Photothermal Conversion Efficiency for Cancer Theranostics

Surface charge transition nano-theranostics based on ultra-small Fe3O4 nanoparticles for enhanced photodynamic and photothermal therapy against nasopharyngeal carcinoma